In dipyridamole-treated glioma cells, the levels of PERK/eIF2α phosphorylation paralleled with YAP1 phosphorylation and YAP1 reduction, while the pharmacological and genetic inhibition of ER stress alleviated dipyridamole-induced changes in YAP1. Here, EIF2AK3 is linked to central nervous system cancer.